Study on COVID-19 and metabolic disorders pulled before it began
NCT ID NCT04645498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to track how COVID-19 infection might worsen the condition of people with inherited metabolic diseases (IMD). Researchers planned to collect information from French patients with IMD who had or had COVID-19 to see how often their metabolic disease got worse. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Claude Huriez Chu Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19